XL413

• Target:

  Cholecystokinin Receptor|||Casein Kinase|||Pim|||CDK

• Related Pathways:

  Chromatin/Epigenetic|||Cell Cycle/Checkpoint|||JAK/STAT signaling|||Stem Cells|||Metabolism|||GPCR/G Protein

• Purity:

  >99.99%

• Bioactivity:

  XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells.

• Smiles:

  O=C1C2=C(C=3C(O2)=CC=C(Cl)C3)NC(=N1)[C@@H]4CCCN4

• Molecular Formula:

  C14H12ClN3O2

• Molecular Weight:

  289.72

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  1169558-38-6